GTS Securities’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,136
Closed -$210K 1297
2024
Q3
$210K Sell
2,136
-112
-5% -$14.5K ﹤0.01% 3610
2024
Q2
$368K Buy
2,248
+540
+32% +$76.9K ﹤0.01% 2959
2024
Q1
$260K Buy
1,708
+1,056
+162% +$176K ﹤0.01% 3118
2023
Q4
$205K Buy
+652
New +$236K ﹤0.01% 3558

Other funds holding AGL

GTS Securities's AGL Position: Q4 2025 in Review

GTS Securities sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 804 shares — an estimated $20.7K sold.

GTS Securities first reported a position in AGL in Q2 2024 and held it in 3 quarters. The position peaked at $257K in Q2 2024. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • GTS Securities reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • GTS Securities sold 804 Agilon Health shares in Q4 2025, an estimated $20.7K.
  • GTS Securities first reported a position in Agilon Health in Q2 2024 and held it in 3 quarters.
  • GTS Securities's Agilon Health position peaked at $257K in Q2 2024.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on GTS Securities's 13F filing for Q4 2025, filed 13 Feb 2026.